Inactivation of pulmonary surfactant and the treatment of acute lung injuries

Pediatric Pathology and Molecular Medicine

Volumn 20, Issue 6, 2001, Pages 519-536

  Taeusch, H W ^a   Keough, K M W ^a  

^a SFGH   (United States)

Author keywords

Acute lung injury; Inactivation; Nonionic polymers; Polyethylene glycol; Pulmonary surfactant; Surfactant proteins

Indexed keywords

LUNG SURFACTANT; POLYMER; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

CONCENTRATION (PARAMETERS); HUMAN; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG INJURY; PRIORITY JOURNAL; PROTEIN PROCESSING; RESPIRATORY DISTRESS SYNDROME; REVIEW;

ADULT; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFANT, NEWBORN; LUNG; MECONIUM ASPIRATION SYNDROME; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURFACE-ACTIVE AGENTS;

EID: 0034770724     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15227950152625819     Document Type: Review

References (82)

1. Pathogenesis and treatment of the adult respiratory distress syndrome
2. Respiratory mechanics in the acute respiratory distress syndrome
3. The American-European consensus conference on ARDS, part 2
4. Ventilator-induced injury: From barotrauma to biotrauma
5. Double-blind controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock
6. Altered surface tension of lung extracts and lung mechanics
7. A protein from airways of premature lambs that inhibits surfactant function
8. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia
9. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids
10. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity
11. Biophysical inhibition of synthetic lung surfactants
12. The role of palmitic acid in pulmonary surfactant: Enhancement of surface activity and prevention of inhibition by blood proteins
13. Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins
14. Surfactant protein B: Lipid interactions of synthetic peptides representing the amino-terminal amphiphathic domain
15. Differential sensitivity to fibrinogen inhibition of SP-C vs SP-B-based surfactants
16. Phospholipases introduced into the hypophase affect the surfactant film outlining a bubble
17. Inactivation of pulmonary surfactant films by subphase exchange
18. Influence of bilirubin on surface tension properties of lung surfactant
19. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome
20. Inhibition of pulmonary surfactant by oleic acid: Mechanisms and characteristics
21. Surfactant displacement by meconium free fatty acids: An alternative explanation for atelectasis in meconium aspiration syndrome
22. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity
23. Phosphocholine reverses inhibition of pulmonary surfactant caused by C-reactive protein
24. Generation of lysophospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by direct surfactant protein A-phospholipase A2 protein interaction
25. Pulmonary surfactant subtypes in a newborn piglet model of meconum aspiration syndrome
26. Stabilization of lung surfactant particles against conversion by a cycling interface
27. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies
28. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro
29. Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum
30. Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents
31. Synthetic surfactant proteins: Prophylaxis vs. rescue
32. Characterization of bovine surfactant for infants with respiratory distress syndrome
33. Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant
34. Protein composition and surface activity of commercial surfactant preparations
35. Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury
36. Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant preparations
37. Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C
38. Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits
39. Can steroids ameliorate meconium aspiration syndrome in piglets?
40. Morphology and function of pulmonary surfactant inhibited by meconium
41. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages
42. Inactivation of the integrin 36 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lungs and skin
43. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production
44. Surfactant protein A activates NFkB in THP-1 monocytic cell line
45. Interactions of surfactant protein A with epithelial cells and phagocytes
46. Immunomodulatory functions of surfactant
47. Surfactant and the adult respiratory distress syndrome
48. Surfactant for acute respiratory distress syndrome
49. Surfactant alterations in severe pneumonia, ARDS, and cardiogenic lung edema
50. Bovine surfactant therapy for patients with acute respiratory distress syndrome
51. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome
52. Bronchopulmonary segmental lavage with surfaxin (KL-4 surfactant) for ARDS
53. Treatment of patients with rSP-C surfactant
54. Meconium aspiration syndrome - Prevention and treatment
55. Surfactant replacement therapy for meconium aspiration syndrome
56. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure
57. Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration
58. Surfactant replacement reverses respiratory failure induced by intratracheal endotoxin in rats
59. Intratracheal aerosolization of endotoxin (LPS) in the rat: A comprehensive animal model to study adult (acute) respiratory distress syndrome
60. Alveolar neutrophils in endotoxin-induced and bacterai-induced acute lung injury in rats
61. Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide
62. Mechanisms of surfactant dysfunction in early acute lung injury
63. Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats
64. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome
65. Acid aspiration induced lung injury
66. Membrane attack complex of complement and neutrophils mediate the injury of acid aspiration
67. Prevention of respiratory failure after hydrochloric acid aspiration by intratracheal surfactant instillation in rats
68. Effects of lung surfactant factor treatment on gas exhange and histopathological changes in an animal model of ARDS: Comparison of recombinant LSF with bovine LSF
69. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo
70. Inactivation of surfactant in rat lungs
71. Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury
72. Surfactant lavage for meconium aspiration syndrome: A pilot study
73. Liquid assisted ventilation: An alternative ventilatory strategy for acute meconium aspiration injury
74. Inactivation of surfactant by meconium in vitro is reversed by surfactant proteins
75. Dextran attenuates surfactant inhibitory action of albumin
76. Introduction to biotechnical and biomedical applications of poly(ethylene glycol)
77. Nonionic polymers reverse inactivation of surfactant by meconium and other substances
78. Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration
79. Polymer-surfactant treatment of meconium-induced acute lung injury
80. Direct measurement of PEG induced depletion attraction between bilayers
81. Effect of water-soluble polymers on the state of aggregation, vesicle size, and phase transformations in mixtures of phosphatidyl-choline and sodium cholate
82. Aggregation of phospholipd vesicles by water-soluble polymers